Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naive Stage IV PD-L1<sup>+</sup> Non-Small-Cell Lung Cancer Patients
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27034243